Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Active Surveillance and Identification of Prognostic Factors for Progression in Early Stage Renal Cell Carcinoma

NCT01305330 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01305330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01305330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Active Surveillance and Identification of Prognostic Factors for Progression in Early Stage Renal Cell Carcinoma
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
August 31, 2004
Completion date
December 31, 2019
Enrollment
137 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with newly diagnosed small renal masses(<4cm)